Steroid response to therapy in prostatic cancer

Steroid response to therapy in prostatic cancer.

IFTEEN years have passed since Huggins and F Hodgeslz first demonstrated the marked response of patients with prostatic cancer to castration and estrogen therapy. This response has become thoroughly established. Patients eventually relapse from this treatment, and there is a growing body 01 evidence that the relapse is frequently associated with increased production of adrenal androgen. It is n...

[Neoadjuvant therapy for prostatic cancer].

Neoadjuvant therapy for prostatic cancer might be important to increase cure rates of the disease and preservability of the organs. There were 43 cases in a period of 1975-1990 in which total prostatectomy were performed after neoadjuvant therapy. According to the clinical stage, there were 14 cases in B, 23 in C, 4 in D1 and 2 in D2. The median duration of neoadjuvant therapy was 4 months. Cli...

Long term response to steroid therapy in Rasmussen encephalitis

Rasmussen encephalitis (RE) is a severe and progressive focal epilepsy of unknown origin that leads to deterioration of motor and cognitive function. In a previous study, we described positive effect of high doses of steroids during the first year after the onset of RE. The objective of this study was to evaluate this therapy at long term. We reviewed 11 patients (7 girls and 4 boys) with RE of...

Laser Therapy in Localized Prostatic Cancer

Steroid hormone receptors in prostatic hyperplasia and prostatic carcinoma.

One hundred and six prostatic tissue samples obtained from transurethral resection were analysed for androgen and estrogen receptors. In 62 of these, progesterone and glucocorticoid receptors were also assayed. Steroid receptors were assayed using single saturation dose 3H-labelled ligand assays. Ninety percent of the 97 prostatic hyperplasia tissues and six of the nine prostatic carcinoma tiss...